Skip to main content

Table 6 Tumor response by disease type

From: Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio

Disease

Patients

Tumor absorbed dose (Gy)

Tumor response

Colorectal cancer

15

136.7 (43.4–494.8)

47%

Hepatocellular carcinoma

5

135.2 (57.0–310.0)

80%

Neuroendocrine tumors

10

123.6 (40.1–262.7)

100%

Other

10

89.6 (56.2–208.4)

60%